The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: Can the results of FDG PET/CT influence patients' treatment decision making?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 1, 2011, Pages 64-73

  Bilici, Ahmet ^a,d   Ustaalioglu, Bala Basak Oven ^a   Şeker, Mesut ^a   Kefeli, Umut ^a   Canpolat, Nesrin ^b   Tekinsoy, Bulent ^c   Ozugur, Sule ^b   Gumus, Mahmut ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b stanbul Ko uyolu Yüksek htisas Training and Research Hospital   (Turkey)

^c Medipol Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

Clinical management; Diagnostic CT; FDG; Gastric cancer; PET CT; Recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINATE CALCIUM; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MALE; PATIENT ASSESSMENT; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TREATMENT PLANNING; DECISION MAKING; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SCINTISCANNING; STOMACH TUMOR; WHOLE BODY IMAGING;

ADULT; AGED; DECISION MAKING; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; RETROSPECTIVE STUDIES; ROC CURVE; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 79551544527     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1611-1     Document Type: Article

References (34)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 10.1200/JCO.2005.05.2308 16682732 (Pubitemid 46655601)
2. CC Boring TS Squires T Tong 1993 Cancer statistics, 1993 CA Cancer J Clin 43 7 26 1:STN:280:DyaK3s7jslWitw%3D%3D 10.3322/canjclin.43.1.7 8422609
3. T Starzyńska 2007 Molecular epidemiology of gastric cancer Dig Dis 25 222 224 10.1159/000103889 17827944 (Pubitemid 350194172)
4. C Kunisaki H Makino H Akiyama Y Otsuka HA Ono T Kosaka, et al. 2008 Clinical significance of the metastatic lymph-node ratio in early gastric cancer J Gastrointest Surg 12 542 549 10.1007/s11605-007-0239-3 17851724
5. RE Schwarz K Zagala-Nevarez 2002 Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy Ann Surg Oncol 9 394 400 10.1007/BF02573875 11986192
6. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg 87 236 242 1:STN:280: DC%2BD3c7jslymsQ%3D%3D 10.1046/j.1365-2168.2000.01360.x 10671934 (Pubitemid 30088655)
7. Y Kodera S Ito Y Yamamura Y Mochizuki M Fujiwara K Hibi, et al. 2003 Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit Ann Surg Oncol 10 898 902 10.1245/ASO.2003.12.009 14527908 (Pubitemid 40486854)
8. J Whiting T Sano M Saka T Fukagawa H Katai M Sasako 2006 Follow-up of gastric cancer: a review Gastric Cancer 9 74 81 10.1007/s10120-006-0360-0 16767361 (Pubitemid 43890702)
9. KW Kim BI Choi JK Han TK Kim AY Kim HJ Lee, et al. 2002 Postoperative anatomic and pathologic findings at CT following gastrectomy Radiographics 22 323 336 10.1148/rg.226025060 11896222
10. HK Ha HH Kim HS Kim MH Lee KT Kim KS Shinn 1993 Local recurrence after surgery for gastric carcinoma: CT findings AJR Am J Roentgenol 161 975 977 1:STN:280:DyaK2c%2FpvFWqtw%3D%3D 8273639
11. D Mullin A Shirkhoda 1985 Computed tomography after gastrectomy in primary gastric carcinoma J Comput Assist Tomogr 9 30 33 1:STN:280: DyaL2M7gsFKmtA%3D%3D 10.1097/00004728-198501000-00006 3968275 (Pubitemid 15199631)
12. HR Schelbert CK Hoh HD Royal M Brown MN Dahlbom F Dehdashti, et al. 1998 Procedure guideline for tumor imaging using fluorine-18-FDG J Nucl Med 39 1302 1305 1:STN:280:DyaK1czjt1Skug%3D%3D 9669415 (Pubitemid 28326172)
13. L Kostakoglu H Agress Jr SJ Goldsmith 2003 Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 315 340 10.1148/rg.232025705 12640150
14. A Stahl K Ott WA Weber K Becker T Link JR Siewert, et al. 2003 FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings Eur J Nucl Med Mol Imaging 30 288 295 1:CAS:528:DC%2BD3sXms1Cmsw%3D%3D 10.1007/s00259-002-1029-5 12552348
15. E Mochiki H Kuwano H Katoh T Asao N Oriuchi K Endo 2004 Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer World J Surg 28 247 253 10.1007/s00268-003-7191-5 14961197 (Pubitemid 38375523)
16. M Yun JS Lim SH Noh WJ Hyung JH Cheong JK Bong, et al. 2005 Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT J Nucl Med 46 1582 1588 16204706
17. SK Kim KW Kang JS Lee HK Kim HJ Chang JY Choi, et al. 2006 Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer Eur J Nucl Med Mol Imaging 33 148 155 10.1007/s00259-005-1887-8 16228236 (Pubitemid 43152881)
18. HW Yeung H Macapinlac M Karpeh RD Finn SM Larson 1998 Accuracy of FDG-PET in gastric cancer. Preliminary experience Clin Positron Imaging 1 213 221 10.1016/S1095-0397(98)00018-1 14516555 (Pubitemid 128784448)
19. T De Potter P Flamen E Van Cutsem F Penninckx L Filez G Bormans, et al. 2002 Whole-body PET with FDG for the diagnosis of recurrent gastric cancer Eur J Nucl Med Mol Imaging 29 525 529 10.1007/s00259-001-0743-8 11914891
20. H Jadvar R Tatlidil AA Garcia PS Conti 2003 Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography Clin Radiol 58 215 221 1:STN:280:DC%2BD3s7isFCntw%3D%3D 10.1016/S0009-9260(02)00477-4 12639527 (Pubitemid 36335946)
21. L Sun XH Su YS Guan WM Pan ZM Luo JH Wei, et al. 2008 Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results World J Gastroenterol 14 4627 4632 10.3748/wjg.14.4627 18698676
22. MJ Park WJ Lee HK Lim KW Park JY Choi BT Kim 2009 Detecting recurrence of gastric cancer: the value of FDG PET/CT Abdom Imaging 34 441 447 10.1007/s00261-008-9424-4 18543017
23. SH Sim YJ Kim DY Oh SH Lee DW Kim WJ Kang, et al. 2009 The role of PET/CT in detection of gastric cancer recurrence BMC Cancer 9 73 10.1186/1471-2407-9- 73 19250554
24. HH Chung WJ Kang JW Kim NH Park YS Song JK Chung, et al. 2007 Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings Eur J Nucl Med Mol Imaging 34 480 486 10.1007/s00259-006-0260-x 17089122 (Pubitemid 46426988)
25. KF Hubner TW McDonald JG Niethammer GT Smith HR Gould E Buonocore 1993 Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG) Gynecol Oncol 51 197 204 1:STN:280:DyaK2c7gt1Kjsw%3D%3D 10.1006/gyno.1993.1272 8276294
26. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10.1093/jnci/92.3.205 10655437
27. M Sasako M Saka T Fukagawa H Katai T Sano 2007 Surgical treatment of advanced gastric cancer: Japanese perspective Dig Surg 24 101 107 1:STN:280:DC%2BD2s3pt1Khug%3D%3D 10.1159/000101896 17446702 (Pubitemid 46788275)
28. A Cuschieri S Weeden J Fielding J Bancewicz J Craven V Joypaul, et al. 1999 Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 1522 1530 1:STN:280:DyaK1M3gt1Ortg%3D%3D 10.1038/sj.bjc.6690243 10188901
29. CY Chen JS Hsu DC Wu WY Kang JS Hsieh TS Jaw, et al. 2007 Gastric cancer: preoperative local staging with 3D multi-detector row CT-correlation with surgical and histopathologic results Radiology 242 472 482 10.1148/radiol. 2422051557 17255419 (Pubitemid 46146200)
30. BC Kang JH Kim KW Kim DY Lee SY Baek SW Lee, et al. 2000 Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology Abdom Imaging 25 14 24 1:STN:280: DC%2BD3c7hvVGjug%3D%3D 10.1007/s002619910003 10652915 (Pubitemid 30033440)
31. T Fukuya H Honda T Hayashi K Kaneko Y Tateshi T Ro, et al. 1995 Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer Radiology 197 705 711 1:STN:280:DyaK28%2Fnt1ymtw%3D%3D 7480743
32. P Flamen A Lerut E Van Cutsem JP Cambier A Maes W De Wever, et al. 2000 The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J Thorac Cardiovasc Surg 120 1085 1092 1:STN:280:DC%2BD3M%2FntF2ntA%3D%3D 10.1067/mtc.2000.110464 11088030
33. P Flamen S Stroobants E Van Cutsem P Dupont G Bormans N De Vadder, et al. 1999 Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer J Clin Oncol 17 894 901 1:STN:280:DyaK1M7mvVyguw%3D%3D 10071281
34. L Kostakoglu R Hardoff R Mirtcheva SJ Goldsmith 2004 PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake Radiographics 24 1411 1431 10.1148/rg.245035725 15371617